A parasite resistant to the top anti-malaria drug is confined to Southeast Asia and has not yet spread to sub-Saharan Africa as feared. Scientists confirmed the containment by conducting the first global study that maps resistance to "artemisinin," currently the leading anti-malaria drug.VIDEOGRAPHIC
